Point72 Asset Management, L.P. 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:21 pm Sale | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Point72 Asset Management, L.P. | 1,903,943 1.300% | -4,823,266 (-71.70%) | Filing |
| 2026-01-05 4:12 pm Purchase | 2026-01-02 | 13G | OVID THERAPEUTICS INC OVID | Point72 Asset Management, L.P. | 6,727,209 5.100% | 6,727,209 (New Position) | Filing |